L44-10904-66866
4 vaccinations
3 coded responses
30 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 986 / WA
- Registered
- 2021-12-15
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-02-01
Dose 2 — Pfizer-BioNTech
-
2021-12-15
Registered in v-safe
-
2021-12-15
Dose 3 — Pfizer-BioNTech
- 2021-12-15
- 2021-12-16
- 2021-12-17
- 2021-12-18
- 2021-12-19
- 2021-12-20
- 2021-12-21
- 2021-12-22
-
2021-12-29
Survey response — day 14, dose 3MedDRA: Nasal congestion, Nasal discomfort, Nasal dryness — Feeling: GoodFree text: Nasal irritation, dryness and slight congestion.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-05
- 2022-01-12
- 2022-01-19
- 2022-01-26
- 2022-03-16
-
2022-06-15
Survey response — 6 months, dose 3MedDRA: Cough, Dyspnoea, Oropharyngeal pain, Respiratory tract congestion — Feeling: Good · Be unable to work or attend schoolFree text: Cough, SOB, congestion, sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-10-31
Dose 4 — Pfizer-BioNTech
- 2022-10-31
- 2022-11-01
-
2022-11-02
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2022-11-03
- 2022-11-04
- 2022-11-05
- 2022-11-06
- 2022-11-07
- 2022-11-14
- 2022-11-21
- 2022-11-28
- 2022-12-05
- 2022-12-12
- 2023-01-30
-
2023-05-01
Survey response — 6 months, dose 4MedDRA: Delivery — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-05-01
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2023-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | No |
| 2 | 2021-02-01 | Pfizer-BioNTech | No |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
| 4 | 2022-10-31 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — day 14, dose 3
Symptoms: Nasal irritation, dryness and slight congestion.
Release 12 — 6 months, dose 3
Symptoms: Cough, SOB, congestion, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasal discomfort | · | · | ✓ |
| SD | Nasal dryness | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release